Cite

HARVARD Citation

    Lai, C. et al. (2014). Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut. 63 (6), pp. 996-1004. [Online]. 
  
Back to record